Recent progress in surgical treatment of pancreatic cancer
10.3760/cma.j.cn113855-20241210-00764
- VernacularTitle:胰腺癌新辅助及转化治疗热点聚焦
- Author:
Xiaodong TIAN
1
;
Yongqi DENG
1
;
Yinmo YANG
1
Author Information
1. 北京大学第一医院肝胆胰外科，北京 100034
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Surgical procedures,operative;
Multidisciplinary team;
Neoadjuvant therapy;
Conversion therapy
- From:
Chinese Journal of General Surgery
2025;40(1):23-27
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is a severe malignant tumor that poses a significant threat to human health worldwide, with its incidence and mortality rates increasing annually, especially in economically developed regions. The progress of surgical treatment is of great significance in improving the prognosis of pancreatic cancer patients. This article reviews the recent progress in surgical treatment strategies for pancreatic cancer, with a particular emphasis on the multidisciplinary team (MDT) approach, neoadjuvant therapy, conversion therapy, and the assessment of the effectiveness of neoadjuvant/conversion therapy. The MDT approach, by integrating the strengths of multiple disciplines, provides personalized treatment plans for patients, improving the resection rate and survival rate of patients with pancreatic cancer. Neoadjuvant and conversion therapy provide surgical opportunities for patients with advanced pancreatic cancer, improving their prognosis. Additionally, accurate assessment of treatment effects is crucial for determining the timing and method of surgery.
